Check Out Our CD40 mAb Phase II Poster at ASCO2024!
ASCO 2024 | Biocytogen/Eucure Biopharma to Present Two Phase II Clinical Studies of CD40 Agonistic Antibody YH003 Biocytogen’s wholly owned subsidiary Eucure Biopharma today…
Read moreJoin us at Booth D23 at BIO KOREA 2024! May 8-10
Biocytogen’s APAC business development team is excited to exhibit and host 1-on-1 meetings at BIO KOREA 2024, taking place from May 8-10, 2024 in Seoul,…
Read moreImmuno-Oncology Summit Europe 2024: April 23-25
Visit Our Bispecific Antibody Poster at IO Summit Europe 2024! Biocytogen’s antibody Business Development & Licensing team is excited to attend the upcoming Immuno-Oncology…
Read moreFestival of Biologics USA 2024: April 15-17
Thank you to those who joined us at the Festival of Biologics USA 2024 from April 15-17 in San Diego, CA! Our Poster titled…
Read moreWebinar: Empowering Discovery and Development of Bispecific ADCs With a Common Light Chain Antibody Library and a Novel Linker/Payload
About the webinar Bispecific ADCs are a growing trend in the ADC field, offering improved efficacy and safety for the treatment of heterogeneous solid…
Read moreAACR 2024 Posters
We are thrilled to have had the opportunity to attend the American Association for Cancer Research (AACR) Annual Meeting 2024 in San Diego, CA. Your…
Read moreBIO-Europe Spring 2024 | Schedule 1-on-1 Meetings with Biocytogen
Biocytogen’s antibody BD and licensing team is pleased to attend and host 1-on-1 meetings at BIO-Europe Spring, taking place March 18-20, 2024 in Barcelona, Spain.…
Read moreJoin us at World ADC London 2024: Mar 13-14
Join us at the World ADC London 2024 conference in London, UK from March 13-14! Our Chief Scientific Officer and Senior Director of New Drug…
Read moreJoin us at SAPA-GP Annual Conference 2024: Mar 8-9
Join us at the SAPA-GP Annual Conference 2024 in Pennsylvania from March 8-9, 2024! Whether you need humanized models, pharmacology services, or are seeking…
Read moreWebinar: Translational Animal Models of Atopic Dermatitis (AD) for Preclinical Studies
Our webinar “Translational Animal Models of Atopic Dermatitis (AD) for Preclinical Studies" was live at 12PM EDT on March 27, 2024. About the webinar: Atopic…
Read more